montelukast sodium
Generic: montelukast sodium
Labeler: rising pharma holdings, inc.Drug Facts
Product Profile
Brand Name
montelukast sodium
Generic Name
montelukast sodium
Labeler
rising pharma holdings, inc.
Dosage Form
TABLET
Routes
Active Ingredients
montelukast sodium 10 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
16571-100
Product ID
16571-100_c3c93ca9-9367-4426-b310-5507dd588b08
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA209012
Listing Expiration
2026-12-31
Marketing Start
2023-06-01
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
16571100
Hyphenated Format
16571-100
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
montelukast sodium (source: ndc)
Generic Name
montelukast sodium (source: ndc)
Application Number
ANDA209012 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 10 mg/1
Packaging
- 90 TABLET in 1 BOTTLE (16571-100-09)
- 1000 TABLET in 1 BOTTLE (16571-100-10)
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "c3c93ca9-9367-4426-b310-5507dd588b08", "openfda": {"upc": ["0316571100095"], "unii": ["U1O3J18SFL"], "rxcui": ["200224"], "spl_set_id": ["75723c5a-3c9e-468a-bc65-57b4c755889a"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET in 1 BOTTLE (16571-100-09)", "package_ndc": "16571-100-09", "marketing_start_date": "20230601"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (16571-100-10)", "package_ndc": "16571-100-10", "marketing_start_date": "20230601"}], "brand_name": "MONTELUKAST SODIUM", "product_id": "16571-100_c3c93ca9-9367-4426-b310-5507dd588b08", "dosage_form": "TABLET", "pharm_class": ["Leukotriene Receptor Antagonist [EPC]", "Leukotriene Receptor Antagonists [MoA]"], "product_ndc": "16571-100", "generic_name": "MONTELUKAST SODIUM", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "MONTELUKAST SODIUM", "active_ingredients": [{"name": "MONTELUKAST SODIUM", "strength": "10 mg/1"}], "application_number": "ANDA209012", "marketing_category": "ANDA", "marketing_start_date": "20230601", "listing_expiration_date": "20261231"}